CHAPTER 70 Cardiopulmonary Bypass
7 List the two basic types of oxygenators
14 Discuss myocardial protection during cardiopulmonary bypass. What elements should be in place to optimize myocardial protection?
16 Review the physiologic responses to cardiopulmonary bypass
Stress hormones, including catecholamines, cortisol, angiotensin, and vasopressin, increase in part because of decreased metabolism of these substances.18 Develop an appropriate checklist for discontinuing bypass
Check acid-base balance, ensuring neutral pH, base deficit, PCO2, hematocrit, electrolytes, and platelet count.
Evaluate TEE, looking for signs of ischemia (regional wall motion abnormalities) along with evaluation of valves, specifically in cases of valve replacement or repair.21 What are some therapies for the patient with impaired cardiac performance or difficulty weaning from cardiopulmonary bypass?
Typical scenarios encountered during the weaning process include reduced vascular resistance (so-called vasoplegia), which often requires vasopressor support. Contractility problems with the heart itself necessitate inotropic agents or possibly an aortic balloon pump to assist in the weaning from bypass. Right heart dysfunction and/or pulmonary hypertension may also complicate weaning from bypass. Agents such as nitric oxide or vasodilator therapy targeted toward the pulmonary system can be useful in this situation. TEE is invaluable in guiding these decisions along with interpretation of the pulmonary artery catheter. Inotropic and vasodilator therapies are discussed in Chapter 15.
22 Review the central nervous system complications of cardiopulmonary bypass
KEY POINTS: Cardiopulmonary Bypass 
23 What might be done to decrease the incidence of such complications?
Reversible factors may be identified before surgery. For instance, patients with significant carotid stenosis may require correction of this problem before CPB (perhaps at the same surgery). Significant aortic atherosclerosis is an independent risk factor for stroke. Therefore avoiding aortic cross-clamp is important; an off-pump surgical strategy may benefit these patients.
Perioperative aspirin therapy and minimally invasive off-pump coronary artery surgery may also have some benefit.
Meticulous attention intraoperatively to decreasing cerebral oxygen consumption through hypothermia, along with maintenance of perfusion pressure and mixed venous oxygen levels, may optimize cerebral supply and demand.1. Gravlee G. Cardiopulmonary Bypass, Principles and Practice, ed 3. Philadelphia: Lippincott Williams & Wilkins, 2008.
2. Hogue C., Palin C., Arrowsmith J. Cardiopulmonary bypass management and neurologic outcomes: an evidence-based appraisal of current practices. Anesth Analg. 2006;103:21-37.
3. Mora-Mangano C.T., Chow J.L., Kanevsky M. Cardiopulmonary bypass and the anesthesiologist. In: Kaplan J.A., editor. Cardiac anesthesia. ed 5. Philadelphia: Saunders Elsevier; 2006:893-935.
4. Murphy G.J., Angelini G.D. Side effects of cardiopulmonary bypass: what is the reality? J Card Surg. 2004;19:481-488.
